Samsung recently announced that the Galaxy Watch line has been FDA-approved for detecting sleep apnea, marking a significant advancement in the smartwatch industry, which has been increasingly focused on health and fitness features. While heart monitoring and blood oxygen detection have been the primary areas of focus in recent years, there has been speculation about the potential for non-invasive glucose monitoring, which could greatly benefit millions of people living with diabetes.
Obstructive sleep apnea (OSA) is a widespread problem, affecting approximately 39 million Americans, according to the National Council on Aging. Globally, this number rises to a staggering 936 million, with the majority of affected individuals remaining undiagnosed, as reported by the American Academy of Sleep Medicine.
OSA, the more common type of sleep apnea, occurs when the sleeper's upper airway becomes blocked, leading to restricted breathing. This condition is associated with an increased risk of developing various health issues, including type 2 diabetes, heart and kidney failure, high blood pressure, and stroke.
Samsung stated:“The sleep apnea feature will enable users over the age of 22 who have not been diagnosed with sleep apnea to detect signs of moderate to severe obstructive sleep apnea (OSA) over a two-night monitoring period, a common and chronic sleep condition that often goes undiagnosed and untreated,” “To utilize the feature, users will be able to simply track their sleep twice for more than four hours within a ten-day period.”
Click here to read the original news story.